QG AN, 1997, Neurotoxicity and possible roles of aspartic acid, glutamic acid and GABA in some neurologic disorders, Biogenic Amines, 13, 565
Ali QG, 1996, Multiple sclerosis and neurotransmission, Biogenic Amines, 12, 353
10.1111/j.1600-0404.1986.tb04643.x
10.1016/0006-8993(78)90300-1
10.1096/fasebj.10.10.8751715
10.1523/JNEUROSCI.18-16-06241.1998
10.1016/0002-9343(91)90278-6
10.1016/S0079-6123(08)61151-6
10.1152/ajpcell.1996.271.5.C1424
10.1523/JNEUROSCI.18-05-01633.1998
10.1097/00000658-199504000-00003
10.1016/0006-8993(92)91004-X
10.1046/j.1471-4159.1997.68062227.x
10.1016/S0891-5849(96)00240-7
10.1046/j.1471-4159.1994.63030910.x
10.1016/0891-5849(93)90144-J
10.1046/j.1471-4159.1995.65031342.x
10.1016/0165-5728(95)00061-6
10.1016/S0891-5849(96)00404-2
Brenner T, 1997, Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis, J Immunol, 158, 2940, 10.4049/jimmunol.158.6.2940
10.1016/0304-3940(95)11703-Y
10.1016/0014-5793(95)00401-T
Calabrese V, 1995, Changes in cerebrospinal fluid levels of malondialdehyde and glutathione reductase activity in multiple sclerosis. Intern, J Clin Pharm Res, 14, 119
10.1016/0304-3940(95)12173-0
10.1016/0925-4439(93)90078-F
10.1016/0304-3940(95)12101-9
10.1016/0960-5428(95)00031-3
10.1152/ajpcell.1994.266.6.C1650
10.1111/j.1749-6632.1994.tb21789.x
10.1111/j.1749-6632.1994.tb21789.x
10.1016/S0306-9877(97)90196-1
CorkillDJ WoolleyK GuardS WrightA GallowayWA ThomasSW AskewM BeckettP DavisMH MillerK StablerG GearingA WoodLM(1995)The effect of a novel inhibitor of tumour necrosis factor a (TNFα) processing BB‐1101 in experimental autoimmune encephalomyelitis.Br J Pharmacol8P..
10.1016/S0165-5728(98)00040-X
10.1016/S0165-5728(96)00147-6
10.1016/S0165-5728(98)00078-2
10.1016/S0165-5728(97)00145-8
10.1007/978-1-4757-9480-9_21
10.1016/0197-0186(94)00168-T
10.1097/00005072-199701000-00002
Vries HE, 1997, The blood‐brain barrier in neuroinflammatory diseases, Pharmacol Rev, 49, 143
10.1046/j.1365-2125.1996.03804.x
10.1111/j.1365-2249.1992.tb06430.x
10.1016/0028-3908(93)90096-L
10.4049/jimmunol.160.6.2560
10.1046/j.1471-4159.1997.68051896.x
10.1016/0167-5699(95)80080-8
10.1016/0197-0186(94)00164-P
10.1016/0891-0618(95)00140-9
Fenyk‐Melody JE, 1998, Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene, J Immunol, 160, 2940, 10.4049/jimmunol.160.6.2940
10.1146/annurev.ph.57.030195.003343
Ginsberg MD, 1979, Delayed neurological deterioration following hypoxia, Adv Neurol, 26, 21
10.1001/archneur.1976.00500010007002
10.1191/135245898678909178
10.1111/j.1600-0404.1993.tb04212.x
Gopalakrishna R, 1993, Nitric oxide and nitric oxide‐generating agents induce a reversible inactivation of protein kinase C activity and phorbol ester binding, J Biol Chem, 268, 27180, 10.1016/S0021-9258(19)74235-5
10.1016/0014-5793(93)80269-Z
10.1093/carcin/17.11.2501
Griot C, 1989, Makrophagen bei der zentralnervosen Hundestaupe: Freunde Oder Feinde, Schweizer Archiv Tierheilk, 131, 351
10.3109/10715769009088915
10.1016/S0165-5728(96)00159-2
10.1016/S0165-5728(97)00172-0
10.1016/0014-5793(86)80626-3
10.1016/0006-8993(88)90782-2
10.1016/S0166-2236(96)10071-0
Halliwell B, 1998, Free Radicals in Biology and Medicine
10.1016/0165-5728(95)00104-A
10.1016/0304-3940(93)90898-U
10.3109/10715769309145868
10.1016/0006-8993(95)00832-B
10.1016/0306-9877(93)90052-R
10.2169/internalmedicine.34.734
10.1016/0003-9861(92)90431-U
Janabi N, 1996, Endogenous nitric oxide activates prostaglandin F2 alpha production in human microglial cells but not in astrocytes: a study of interactions between eicosanoids, nitric oxide, and superoxide anion (O2‐) regulatory pathways, J Immunol, 157, 2129, 10.4049/jimmunol.157.5.2129
10.1016/S0361-9230(98)00052-5
Jensen GE, 1986, Glutathione peroxidase activity, associated enzymes and substrates in blood cells from patients with multiple sclerosis ‐ effects of antioxidant supplementation, Acta Pharmacol Toxicol, 59, 450, 10.1111/j.1600-0773.1986.tb02800.x
10.1016/S0149-7634(96)00005-X
10.1002/(SICI)1098-1136(199804)22:4<371::AID-GLIA6>3.0.CO;2-6
10.1016/0014-5793(93)81483-G
10.1001/archneur.1991.00530140091021
10.1016/S0304-3940(97)00235-8
10.1111/j.1600-0404.1997.tb00076.x
10.1523/JNEUROSCI.18-03-01038.1998
10.1111/j.1471-4159.1985.tb05530.x
10.1016/S0006-8993(97)00470-8
10.1016/S0891-5849(98)00019-7
10.1016/S0896-6273(00)80484-5
Liu J, 1996, Expression of type II nitric oxide synthase in primary human astrocytes and microglia: role of IL‐1 beta and IL‐1 receptor antagonist, J Immunol, 157, 3569, 10.4049/jimmunol.157.8.3569
10.1016/0891-5849(95)02147-7
10.1515/bchm.1998.379.2.193
Marchetti P, 1996, Mitochondrial permeability transition triggers lymphocyte apoptosis, J Immunol, 157, 4830, 10.4049/jimmunol.157.11.4830
Merrill JE, 1993, Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide, J Immunol, 151, 2132, 10.4049/jimmunol.151.4.2132
10.1002/(SICI)1097-4547(19970515)48:4<372::AID-JNR9>3.0.CO;2-8
10.1016/S0301-0082(97)00052-X
10.1002/(SICI)1098-1136(199702)19:2<152::AID-GLIA6>3.0.CO;2-2
10.1016/0306-4522(94)90435-9
10.1016/0306-4522(94)00491-M
Naidoo R, 1992, Studies of lipid peroxidation products in cerebrospinal fluid and serum in multiple sclerosis and other conditions, Clin Chem, 38, 2449, 10.1093/clinchem/38.12.2449
10.1016/0197-0186(94)00169-U
10.1016/0076-6879(91)05120-K
10.1016/S0021-9258(17)36703-0
10.1111/j.1365-2990.1996.tb00900.x
10.1111/j.1365-2990.1994.tb01174.x
10.1016/0006-8993(94)91525-3
10.1523/JNEUROSCI.13-04-01441.1993
10.1016/0165-5728(95)00114-H
Owens MW, 1997, Effects of reactive metabolites of oxygen and nitrogen on gelatinase A activity, Am J Physiol, 273, L445
10.1016/S0165-5728(97)00256-7
10.1016/S0301-0082(97)00010-5
10.1016/0891-5849(95)00168-W
10.1002/(SICI)1098-1136(199804)22:4<408::AID-GLIA10>3.0.CO;2-#
Qureshi GA, 1993, Role of neurotransmitter amino acids in multiple sclerosis in exacerbation, remission and chronic progressive course, Biogenic Amines, 10, 39
10.1016/0003-9861(91)90224-7
10.1016/S0021-9258(20)64313-7
10.1097/00005072-199305000-00003
10.1016/0165-5728(94)90238-0
10.1093/brain/120.12.2149
10.1093/brain/120.10.1895
10.1016/S0268-9499(97)80029-X
10.1016/S0167-7306(08)60441-X
10.1016/S0006-8993(97)01543-6
10.1016/0891-5849(95)02183-3
10.1016/S0165-5728(97)00162-8
10.1016/S0021-9258(18)47160-8
10.1016/0165-5728(94)00154-G
10.1111/j.1365-2249.1996.tb08304.x
10.1111/j.1471-4159.1993.tb09802.x
Sahrbacher UC, 1998, Mice with an inactivation of the inducible nitric oxide synthase gene are susceptible to experimental autoimmune encephalomyelitis. Eur, J Immunol, 28, 1330
10.1016/S0165-5728(97)00136-7
10.1002/j.1460-2075.1993.tb05978.x
10.1002/(SICI)1098-1136(199712)21:4<370::AID-GLIA4>3.0.CO;2-7
10.1111/j.1550-7408.1991.tb04435.x
10.1111/j.1600-0404.1977.tb01459.x
10.1111/j.1471-4159.1992.tb08328.x
10.1111/j.1460-9568.1993.tb00934.x
10.1046/j.1471-4159.1996.66031227.x
10.1046/j.1471-4159.1995.65010041.x
10.1016/0006-8993(87)90712-8
10.1177/107385849700300411
Smith KJ, 1998, Nitric oxide donors cause persistent axonal damage: electrically active axons are especially susceptible, Soc Neurosci Abstr, 737, 2
10.1016/0022-510X(82)90168-X
Springfield JR, 1994, Pitfalls in the use of breath pentane measurements to assess lipid peroxidation, J Lipid Res, 35, 1497, 10.1016/S0022-2275(20)40091-4
10.1152/ajpcell.1991.260.5.C910
10.1046/j.1471-4159.1997.68062547.x
10.1046/j.1471-4159.1998.70010432.x
10.1016/0165-5728(93)90178-2
10.1046/j.1365-2362.1997.2250774.x
10.1097/00001756-199707070-00030
10.1016/S0165-5728(98)00124-6
10.1016/0891-5849(96)00170-0
10.1016/0361-9230(96)00159-1
10.1046/j.1471-4159.1994.63010266.x
Thorn SR, 1990, Carbon monoxide‐mediated brain lipid peroxidation in the rat, J Appl Physiol, 68, 997, 10.1152/jappl.1990.68.3.997
10.1046/j.1471-4159.1996.67031014.x
10.1056/NEJM199801293380502
10.1016/0022-510X(88)90130-X
10.1146/annurev.bi.61.070192.001105
10.1016/S0165-5728(97)00013-1
10.1016/0006-8993(93)91003-B
10.1002/(SICI)1098-1136(199703)19:3<190::AID-GLIA2>3.0.CO;2-3
Warren J, 1978, Oxygen immunosuppression: modification of experimental allergic encephalomyelitis in rodents, J Immunol, 121, 315, 10.4049/jimmunol.121.1.315
10.1016/1044-0305(95)00709-1
10.1016/0306-9877(94)90070-1
10.1016/0022-510X(80)90088-X
10.1016/0165-5728(88)90020-3
10.1016/S0891-5849(98)00092-6
10.1016/0092-8674(89)90944-6
Woodroofe MN, 1989, Fc receptor density, MHC antigen expression and superoxide production are increased in interferon‐gamma‐treated microglia isolated from adult rat brain, Immunology, 68, 421
10.1016/0022-510X(96)00164-5
10.1016/S0022-510X(97)00183-4
10.1097/00001756-199609020-00025
10.1046/j.1471-4159.1996.67020566.x
10.1016/0304-3940(95)11490-N
10.1615/CritRevNeurobiol.v10.i3-4.20
10.1016/0165-5728(95)00158-1
10.1016/0165-5728(94)00192-Q
10.1016/0304-3940(94)11187-N
10.1016/0008-8749(92)90131-8
